Massive biobank launches to unlock myeloma mysteries
NCT ID NCT06237803
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects and stores blood and tissue samples from 6,000 people with multiple myeloma and related conditions like smoldering myeloma and MGUS. The goal is to create a shared resource for researchers worldwide to study these diseases and improve patient care. Participants provide samples and basic health information, but no experimental treatments are given.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this biobank could provide a valuable resource for future research into better treatments and understanding of myeloma and related diseases.
- What could go wrong
- This is an observational study, not a treatment trial. It does not test any new therapy, so there is no direct benefit to participants. The samples are for future research, which may or may not lead to medical advances.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTRAMEDULLARY MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O. 'Cardinale G.Panico'
RECRUITINGLecce, Italy
-
A.O. 'SS. Antonio e Biagio'
RECRUITINGAlessandria, Italy
-
A.O. S. Maria
RECRUITINGTerni, Italy
-
A.O. San Camillo-Forlanini
RECRUITINGRoma, Italy
-
A.O. di Rilievo Nazionale A. Cardarelli
RECRUITINGNaples, Italy
-
A.O.Spedali Civili di Brescia
RECRUITINGBrescia, Italy
-
A.O.U. Careggi
RECRUITINGFlorence, Italy
-
A.O.U. Città della Salute e della Scienza di Torino - PO Molinette
RECRUITINGTorino, Italy
-
A.O.U. Maggiore della Carità
RECRUITINGNovara, Italy
-
A.O.U. Policlinico S. Martino - Clinica Ematologica
RECRUITINGGenova, Italy
-
A.O.U. Policlinico S. Martino - Ematologia
RECRUITINGGenova, Italy
-
A.S.U.R. Regione Marche
RECRUITINGCivitanova Marche, Italy
-
AOU Ospedali Riuniti di Ancona
RECRUITINGAncona, Italy
-
Alfred Hospital
RECRUITINGMelbourne, Australia
-
Azienda Ospedaliera Universitaria di Udine
RECRUITINGUdine, Italy
-
Bari-A.O.U. Consorziale Policlinico - Medicina Interna
RECRUITINGBari, Italy
-
Beaumont Hospital, Dublin, Hematology Department
RECRUITINGGalway, Ireland
-
CHUC
RECRUITINGCoimbra, Portugal
-
CHUV
RECRUITINGLausanne, Switzerland
-
Chsj - Hosp. Sao Joao
RECRUITINGPorto, Portugal
-
Clinic of Hematology, University Clinical Center of Serbia
RECRUITINGBelgrade, Serbia
-
Department of Haematology UZ Leuven Gasthuisberg
RECRUITINGLeuven, Belgium
-
Fakultní nemocnice
RECRUITINGOlomouc, Czechia
-
Fakutni nemocnice Ostrava
RECRUITINGOstrava, Czechia
-
Fundação Champalimaud
RECRUITINGLisbon, Portugal
-
HOCH Health Ostschweiz Kantonsspital St.Gallen
RECRUITINGSankt Gallen, Switzerland
-
I.R.C.C.S. Ospedale Casa Sollievo della Sofferenza
RECRUITINGSan Giovanni Rotondo, Italy
-
IPOP Porto
RECRUITINGPorto, Portugal
-
KUK Linz
RECRUITINGLinz, Austria
-
Medical University Vienna
RECRUITINGVienna, Austria
-
Nemocnice Havířov
RECRUITINGHavířov, Czechia
-
Nemocnice Nový Jičín
RECRUITINGNový Jičín, Czechia
-
Nemocnice Pelhrimov
RECRUITINGPelhřimov, Czechia
-
Ospedale S. Eugenio
RECRUITINGRoma, Italy
-
Policlinico S Orsola Malpighi
RECRUITINGBologna, Italy
-
Policlinico S. Matteo Fondazione IRCCS - Pavia
RECRUITINGPavia, Italy
-
Regional General Hospital Alexandra Dept of Clinical Therapeutics
RECRUITINGAthens, Greece
-
Slezská nemocnice
RECRUITINGOpava, Czechia
-
Theagenion Cancer Hospital
RECRUITINGThessaloniki, Greece
-
ULSS8 Berica Ospedale S.Bortolo
RECRUITINGVicenza, Italy
-
Všeobecná Fakultní nemocnice v Praz
RECRUITINGPrague, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact